miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor

Por ZHAO, FENG-YI, HAN, JING, CHEN, XIE-WAN, WANG, JIANG, WANG, XU-DONG, SUN, JIAN-GUO, CHEN, ZHENG-TANG
Publicado no Int J Mol Med (2016)